Total Payments
$5,886
2021 Payments
$31.40
Companies
25
Transactions
354
Medicare Patients
1,018
Medicare Billing
$56,187
Payment Breakdown by Category
Food & Beverage$5,714 (97.1%)
Education$172.42 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,714 | 345 | 97.1% |
| Education | $172.42 | 9 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,221 | 155 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,144 | 53 | $0 (2020) |
| Philips Electronics North America Corporation | $451.78 | 31 | $0 (2020) |
| Genentech USA, Inc. | $416.95 | 25 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $395.44 | 16 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $243.69 | 18 | $0 (2020) |
| CSL Behring | $120.53 | 7 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $113.64 | 4 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $83.68 | 6 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $79.98 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $31.40 | 1 | GlaxoSmithKline, LLC. ($31.40) |
| 2020 | $1,481 | 86 | GlaxoSmithKline, LLC. ($612.84) |
| 2019 | $1,311 | 80 | GlaxoSmithKline, LLC. ($428.43) |
| 2018 | $2,028 | 112 | GlaxoSmithKline, LLC. ($674.64) |
| 2017 | $1,035 | 75 | GlaxoSmithKline, LLC. ($473.56) |
All Payment Transactions
354 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/11/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Respiratory | ||||||
| 11/17/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/12/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2020 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Immunology | ||||||
| 11/05/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2020 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 10/13/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2020 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2020 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Immunology | ||||||
| 09/09/2020 | Philips Electronics North America Corporation | (8876) Vest Therapy Und (Device) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Dental and Oral Health | ||||||
| 09/09/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: RESPIRATORY | ||||||
| 09/02/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2020 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 46 | 46 | $5,743 | $1,473 |
| 2020 | 13 | 972 | 1,126 | $117,236 | $54,714 |
Total Patients
1,018
Total Services
1,172
Medicare Billing
$56,187
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 24 | $2,627 | $931.41 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $1,730 | $541.54 | 31.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 11 | $1,386 | $0 | — |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 153 | 209 | $22,500 | $11,658 | 51.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 51 | 51 | $15,249 | $8,210 | 53.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 113 | 130 | $16,338 | $8,026 | 49.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 71 | $11,168 | $6,413 | 57.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 169 | 207 | $13,317 | $4,981 | 37.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 114 | 127 | $9,652 | $4,724 | 48.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 42 | 43 | $7,826 | $3,811 | 48.7% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 56 | 58 | $4,710 | $1,882 | 40.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 67 | 70 | $3,574 | $1,533 | 42.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 11 | $2,317 | $1,324 | 57.2% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2020 | 33 | 33 | $2,014 | $1,052 | 52.2% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2020 | 35 | 38 | $2,444 | $388.46 | 15.9% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 29 | 31 | $2,738 | $335.56 | 12.3% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 33 | 36 | $3,024 | $272.55 | 9.0% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 11 | 11 | $364.00 | $102.18 | 28.1% |
About Dr. Mark Clark, M.D
Dr. Mark Clark, M.D is a Specialist healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376568691.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Clark, M.D has received a total of $5,886 in payments from pharmaceutical and medical device companies, with $31.40 received in 2021. These payments were reported across 354 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,714).
As a Medicare-enrolled provider, Clark has provided services to 1,018 Medicare beneficiaries, totaling 1,172 services with total Medicare billing of $56,187. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Austin, TX
- Active Since 07/13/2006
- Last Updated 03/04/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1376568691
Products in Payments
- NUCALA (Biological) $982.10
- TRELEGY ELLIPTA (Drug) $583.16
- OFEV (Drug) $547.05
- Esbriet (Biological) $371.63
- ANORO (Drug) $304.77
- SPIRIVA RESPIMAT (Drug) $249.14
- UPTRAVI (Drug) $243.69
- SYMBICORT (Drug) $206.49
- FASENRA (Drug) $171.83
- inCourage (Device) $154.46
- Respiratoriy Care Undiv (Device) $152.22
- DUPIXENT (Biological) $129.68
- Zemaira (Biological) $120.53
- STIOLTO RESPIMAT (Drug) $118.78
- BREO (Drug) $109.02
- ANORO ELLIPTA (Drug) $88.03
- XARELTO (Drug) $83.68
- SMARTVEST (Device) $77.08
- ACTHAR (Biological) $73.46
- Wellcentive Undiv (Device) $72.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Austin
Dr. Amin Al-Ahmad, Md, MD
Specialist — Payments: $1.0M
Specialist $1.0M
Dr. Steven Brotzman, M.d, M.D
Specialist — Payments: $962,398
Specialist $962,398
Dr. Thiru Lakshman, Md, MD
Specialist — Payments: $859,514
Specialist $859,514
Daniel Slaughter, M.d, M.D
Specialist — Payments: $151,066
Specialist $151,066
David Laverty, M.d, M.D
Specialist — Payments: $17,668
Specialist $17,668
Dr. Vivek Mahendru, Md, MD
Specialist — Payments: $15,260
Specialist $15,260